Pain Management Therapeutics Market Grows with Rise in Number of Geriatrics

Transparency Market Research (TMR) states that the leading players in the global pain management therapeutics market are Pfizer, Inc., Merck & Co, Inc., Johnson & Johnson, Endo Health Solutions, and Purdue Pharma LP. “The competition is projected to intensify in the coming years as several manufacturers are likely to be threatened by the entry of generic drug manufacturers,” stated the lead analyst Despite the cutthroat competition, Purdue Pharma LP and Pfizer, Inc. held a 50% share in the global market in 2015.

According to the research report, the global pain management therapeutics market is expected to be worth US$83.0 bn by the end of 2024 from US$60.2 bn in 2015. During the forecast period of 2016 and 2024, the global market is projected to surge at a CAGR of 3.7%. The slow-paced growth of the global market will be attributable to the high prevalence of chronic pain among various patients suffering from complicated medical problems

Obtain Report Details: http://www.transparencymarketresearch.com/pain-management-therapeutics.html

Cancer Pain Management Leads the Way for Global Market

The World Health Organization states that the rising cases of cancer across the world have provided the global market for pain management therapeutics lucrative opportunities. The disease comes with immense pain, which makes life miserable during the treatment as well as after the treatment. These therapeutics are also administered to those who are terminally ill patients who no longer have the strength to fight the pain. Owing to this reason alone, the cancer pain management segment held a share of about 28% in the global pain management therapeutics market in 2015 in terms of revenue.

Geographically, the global pain management therapeutics market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Of all the regions, North America dominated the global market as it held nearly half of the market in in 2015. The efficient healthcare sector of North America, rising expenditure on healthcare, and high level of awareness among patients are expected to fuel the progress of this regional market. Europe is expected to closely follow North America pain management therapeutics market as the region works toward offer better healthcare.

Investments to Develop Improved Molecular Combinations to Boost Market Growth

The growing pool of geriatrics, who are susceptible to a wide range of diseases that can be painful, have been the key consumers of pain management therapeutics in recent years. Arthritis, epilepsy, nerve damage, depression, cancer, diabetic neuropathy, and several other injuries that are seen among the aged are projected to drive the global market in the coming years. The global geriatric population is estimated to reach 2 billion by the end of 2050, raising the demand for pain management therapeutics by leaps and bounds.

The market is also being favored by the growing investments in research and development of new molecular combinations and improved methods of drug delivery. The supportive regulatory reforms that are in support of the drug development are also expected to set the global pain management therapeutic on the path of growth in the near future.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1059

Patent Expiries Threaten Sales of High-earning Drugs

Despite the strong market drivers, the global pain management therapeutics market faces some tough challenges. The expected expiry of blockbuster pain management drugs is likely to hold back the sales for several big players in the market. The inroads by generic drugs will also restrain the sales of high-earning drugs by providing affordable alternatives to patients.

This review is based on Transparency Market Research’s review, titled “Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic; Indication - Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine, Post-operative Pain, Cancer Pain) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

For this study, the market is segmented as follows:

Global Pain Management Therapeutics Market Revenue, by Therapeutics

Anticonvulsants
Antidepressants
Anesthetics
Non-steroidal Anti-inflammatory Drugs (NSAIDS)
Opioids
Oxycodones
Hydrocodones
Tramadol
Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
Antimigraine Agents
Other Non-narcotic Analgesic
Global Pain Management Therapeutics Market Revenue, by Indication

Neuropathic Pain
Fibromyalgia
Chronic Back Pain
Arthritic Pain
Migraine
Post-operative Pain
Cancer Pain
Global Pain Management Therapeutics Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific (APAC)
China
Japan
Rest of the World (RoW)
Brazil
Mexico

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.